[Three-Dimensional Ultrasonic Gait Analysis in Schizophrenic Patients]

Autor: Putzhammer A; Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg. albert.putzhammer@bzk.uni-regensburg.de, Heindl B, Müller J, Broll K, Pfeiff L, Perfahl M, Hess L, Koch H
Jazyk: němčina
Zdroj: Psychiatrische Praxis [Psychiatr Prax] 2003 May; Vol. 30 (Suppl 2), pp. 110-114.
DOI: 10.1055/s-2003-39759
Abstrakt: Schizophrenic disorders as well as neuroleptic treatment can affect locomotion. The study assessed the influence of neuroleptic treatment on human gait via ultrasonic topometric gait analysis. In a control sample the test system proved high test-retest-reliability. Spatial and temporal gait parameters were assessed in schizophrenic patients without neuroleptic treatment (n = 12) and under treatment with conventional neuroleptics (n = 14) and re-assessed after treatment change to the atypical neuroleptic olanzapine in a repeated measures design. After switch from conventional neuroleptics to olanzapine patients showed an increase of gait velocity (p
Databáze: MEDLINE